Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q2 EPS of ($0.65), $0.10 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Advance Auto Parts falls on revenue miss, weak guidance